• Medicine
  • Published in Bratislavske lekarske listy 2005

Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.

@article{Petrkov2005CarvedilolaBW,
  title={Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.},
  author={Margita Petr{\'i}kov{\'a} and Viera Jan{\vc}inov{\'a} and Radom{\'i}r Nos{\'a}l' and Magdalena Majekova and Viera F{\'a}bryov{\'a}},
  journal={Bratislavske lekarske listy},
  year={2005},
  volume={106 1},
  pages={
          20-5
        }
}
BACKGROUND Activated blood platelets play a key role in the genesis of many pathological states. Several studies have documented that beta-blockers can influence platelet aggregation. Carvedilol, a third generation non-selective agent with vasodilatory properties, is successfully used in pathological states accompanied with platelet hyperreactivity, however information on its antiplatelet activity is lacking. OBJECTIVES The aim of this study was to analyse the in vitro effect of carvedilol on… CONTINUE READING